Yahoo Web Search

Search results

  1. As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience.

  2. Ipsen is a mid-sized global biopharmaceutical company, improving patients’ lives through research and innovation in oncology, rare disease and neuroscience.

  3. Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society.

  4. Ipsen designs and manufactures industrial vacuum furnaces, atmosphere furnaces, and controls for thermal processing markets.

  5. en.m.wikipedia.org › wiki › IpsenIpsen - Wikipedia

    Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.

  6. www.linkedin.com › company › ipsenIpsen | LinkedIn

    We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

  7. Ipsen is backed by more than 70 years of experience in heat treating, learn about our history, career opportunities, and locations.

  8. We engineer our vacuum furnaces to achieve demanding specifications for your safety-critical and high-performance parts. Every Ipsen thermal processing solution is backed by expert support for the lifetime of your equipment. Start Your Quote

  9. IPSEN CARES ® (Coverage, Access, Reimbursement & Education Support) serves as a central point of contact among patients/caregivers, healthcare providers, insurance companies, and specialty pharmacies.

  10. Feb 13, 2024 · The FDA has approved Onivyde as part of a multidrug combination dubbed Nalirifox to treat patients with newly diagnosed metastatic pancreatic cancer. Before Tuesday’s approval, Onivyde had been...

  1. People also search for